Pharma & Biotech

Redwire finds itself navigating a complex financial landscape where substantial government contracts contrast sharply with concerning quarterly performance. The space...

Shares of Vera Therapeutics have retreated to a five-day low, reflecting a notable shift in investor sentiment. This pullback coincides...

Shares of BeiGene continued their impressive ascent on the Hong Kong stock exchange, advancing 4.06% today. This gain builds on...

Nuvalent Inc. reported a second-quarter GAAP loss per share of $1.39, a figure that fell outside the range of analyst...

Investors in Denali Therapeutics are facing a period of intense volatility as the biotech firm approaches a critical regulatory milestone....

Assembly Biosciences finds itself at a critical juncture, with its stock caught between compelling long-term potential and immediate selling pressure....

How does a clinical-stage biotechnology firm justify burning through nearly a quarter of a billion dollars in a single quarter?...

New clinical evidence has positioned Novo Nordisk's weight management medication Wegovy for a potential market resurgence. Recent findings demonstrate the...

Centene Corporation’s stock continues to face headwinds as a critical September 8 deadline approaches for investors seeking lead plaintiff status...

Pharmaceutical giant Eli Lilly finds itself navigating a complex pricing landscape as new regulatory measures from the Trump administration compel...